Health
CommentaryClimate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them
By Jayasree K. IyerDecember 11, 2023
CommentaryMillennials and Gen Xers might be the unluckiest caregivers in history. Here’s how their crisis is affecting every workplace
By Bill NovelliDecember 8, 2023
CommentaryInside long COVID’s war on the body: Researchers are trying to find out whether the virus has the potential to cause cancer
By Carolyn BarberNovember 23, 2023
HealthPeter Thiel–cofounded Palantir will overhaul the U.K.’s public health service in a deal worth up to $413M—and people are worried
By Prarthana PrakashNovember 22, 2023
RetailItaly bans lab-grown meat and ‘tofu steak’ in a bid to protect prosciutto and the people who make it
By Ryan HoggNovember 17, 2023
FinanceBiden administration is cracking down on pharmacy middlemen, but they’re so powerful it might be too late to help independent drugstores
By Arthur Allen and KFF Health NewsNovember 16, 2023
RetailSo many Americans are using Novo Nordisk’s blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug
By Ryan HoggNovember 16, 2023
CommentaryOur changing climate is jeopardizing worker health and productivity. Companies need to adapt their operations
By Martine Ferland and Judy MonroeNovember 15, 2023
CommentaryAI will live up to the hype and more unicorns will lose their horns: 10 health care predictions for 2024 from top investors
By Bob Kocher and Bryan RobertsNovember 14, 2023
RetailAvon survived on door-to-door sales for 137 years. Now, it’s opening its first U.K. stores because its customers have given up being at home
By Ryan HoggNovember 14, 2023
HealthJill Biden announces a White House initiative focused on women’s health research: This ‘has been underfunded for decades’
By Alexa MikhailNovember 13, 2023
HealthAmazon reenters health care market with Prime virtual appointment service that costs $9 per month
By The Associated PressNovember 10, 2023
RetailNovo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy
By Ryan HoggNovember 9, 2023
Most Popular
